EPU-17785-27671
4 vaccinations
1 coded response
28 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-04-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Registered in v-safe
-
2021-04-13
Dose 1 — Pfizer-BioNTech
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-29
- 2021-05-04
-
2021-05-10
Dose 2 — Pfizer-BioNTech
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-26
- 2021-06-09
- 2021-06-14
- 2021-06-21
- 2021-08-11
- 2021-11-08
-
2021-12-22
Dose 3 — Moderna
-
2022-09-28
Dose 4 — Moderna
- 2022-10-06
- 2022-10-12
- 2022-10-19
- 2022-10-28
- 2022-11-02
- 2022-11-09
- 2022-12-28
-
2023-03-31
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-10 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Moderna | No |
| 4 | 2022-09-28 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release